Peripheral effects of the endocannabinoid system in energy homeostasis: Adipose tissue, liver and skeletal muscle
- 19 February 2011
- journal article
- review article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 12 (3) , 153-162
Abstract
The endocannabinoid system (ECS) is composed of lipid signalling ligands, their G-protein coupled receptors and the enzymes involved in ligand generation and metabolism. Increasingly, the ECS is emerging as a critical agent of energy metabolism regulation through its ability to modulate caloric intake centrally as well as nutrient transport, cellular metabolism and energy storage peripherally. Visceral obesity has been associated with an upregulation of ECS activity in several systems and inhibition of the ECS, either pharmacologically or genetically, results in decreased energy intake and increased metabolic output. This review aims to summarize the recent advances that have been made regarding our understanding of the role the ECS plays in crucial peripheral systems pertaining to energy homeostasis: adipose tissues, the liver and skeletal muscle.Keywords
This publication has 88 references indexed in Scilit:
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesityJournal of Clinical Investigation, 2010
- Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γJournal of Biological Chemistry, 2010
- Pathogenesis of Insulin Resistance in Skeletal MuscleJournal of Biomedicine and Biotechnology, 2010
- CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesCardiovascular Research, 2009
- Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feedingBritish Journal of Pharmacology, 2009
- AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectivesActa Physiologica, 2009
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in miceJournal of Clinical Investigation, 2008
- Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c‐Fos expression in the hypothalamusBritish Journal of Pharmacology, 2007
- Abdominal obesity and metabolic syndromeNature, 2006
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006